Axsome Therapeutics, Inc.AXSMNASDAQ
LOADING
|||
Year-over-year gross profit growth rate
| Period | Value |
|---|---|
| Q3 2025 | 16.46% |
| Q2 2025 | 22.31% |
| Q1 2025 | 3.16% |
| Q4 2024 | 12.38% |
| Q3 2024 | 21.76% |
| Q2 2024 | 15.15% |
| Q1 2024 | 7.09% |
| Q4 2023 | 25.15% |
| Q3 2023 | 21.76% |
| Q2 2023 | -51.62% |
| Q1 2023 | 294.10% |
| Q4 2022 | 47.97% |
| Q3 2022 | 90.40% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |